|

Cancer Clinical Trials in New York, NY

1898 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal AgentsPhase 3<1 mi
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AMLPhase 2<1 mi
E-Mindfulness Approaches for Living After Breast CancerPhase 3<1 mi
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialPhase 2<1 mi
Colon Adjuvant Chemotherapy Based on Evaluation of Residual DiseasePhase 2/3<1 mi
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN StudyPhase 2/3<1 mi
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL StudyPhase 3<1 mi
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaPhase 3<1 mi
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI TrialPhase 2<1 mi
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerPhase 3<1 mi
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabPhase 3<1 mi
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialPhase 2<1 mi
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Phase 3<1 mi
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung CancerPhase 3<1 mi
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerPhase 2/3<1 mi
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerPhase 3<1 mi
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.Phase 3<1 mi
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerPhase 1/2<1 mi
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent GlioblastomaPhase 2<1 mi
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)Phase 3<1 mi
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaPhase 3<1 mi
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLyPhase 3<1 mi
Project: Every Child for Younger Patients With Cancer—<1 mi
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive MeningiomasPhase 2<1 mi
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabPhase 3<1 mi
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group StudyPhase 1/2<1 mi
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by SurgeryPhase 3<1 mi
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsPhase 3<1 mi
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)Phase 3<1 mi
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung CancerPhase 3<1 mi
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLCPhase 2<1 mi
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung CancerPhase 3<1 mi
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainPhase 3<1 mi
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or LymphomaPhase 3<1 mi
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialPhase 3<1 mi
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerPhase 2/3<1 mi
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney CancerPhase 3<1 mi
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian CancerPhase 3<1 mi
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerPhase 3<1 mi
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung CancerPhase 3<1 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection—<1 mi
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent IohexolPhase 1<1 mi
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryPhase 2<1 mi
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)Phase 2<1 mi
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)Phase 2<1 mi
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerPhase 3<1 mi
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)Phase 2<1 mi
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic CancerPhase 1/2<1 mi
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)Phase 2<1 mi
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal CancerPhase 4<1 mi
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian CancerN/A<1 mi
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerPhase 3<1 mi
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)Phase 3<1 mi
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR TrialPhase 2/3<1 mi
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerPhase 3<1 mi
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate CancerPhase 3<1 mi
Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and LegsPhase 2<1 mi
A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of ChemotherapyPhase 2<1 mi
A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders—<1 mi
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma—<1 mi
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical CancerPhase 2<1 mi
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following TreatmentPhase 2<1 mi
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat CancerPhase 2<1 mi
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate CancerPhase 2<1 mi
Enfortumab Vedotin and Pembrolizumab in People With Bladder CancerPhase 2<1 mi
A Study of Revumenib and Mezigdomide in People With LeukemiaPhase 1/2<1 mi
A Study of Isoquercetin in People With Ovarian CancerPhase 2<1 mi
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin CancerPhase 3<1 mi
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)Phase 1<1 mi
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With CancerN/A<1 mi
Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular LymphomaPhase 1<1 mi
A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate CancerPhase 1<1 mi
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease—<1 mi
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)N/A<1 mi
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER StudyPhase 3<1 mi
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialPhase 3<1 mi
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With GlioblastomaPhase 1<1 mi
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas—<1 mi
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat CancerPhase 3<1 mi
Groningen International Study on Sentinel Nodes in Vulvar Cancer-IIIPhase 2<1 mi
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial CancerN/A<1 mi
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsPhase 3<1 mi
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test ResultsN/A<1 mi
A Study of Opportunistic Salpingectomy to Prevent Ovarian CancerN/A<1 mi
Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology—<1 mi
A Study of Teclistamab and Mezigdomide in People With Multiple MyelomaPhase 1<1 mi
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic ChangePhase 2<1 mi
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial CancerN/A<1 mi
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple MyelomaPhase 1/2<1 mi
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell LymphomaPhase 2<1 mi
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)Phase 2<1 mi
A Study of Reduced Dose Radiation Therapy for People With B-Cell LymphomasPhase 3<1 mi
A Study of Selinexor in People With Wilms Tumors and Other Solid TumorsPhase 2<1 mi
Glioma Developmental and HyperActive Ras Tumor (DHART) Board—<1 mi
Pembrolizumab, Olaparib, and Temozolomide for People With GliomaPhase 2<1 mi
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II StudyPhase 2<1 mi
Kidney Cancer DNA Registry—<1 mi
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell TransplantPhase 2<1 mi
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic LeukemiaPhase 2<1 mi
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)Phase 1<1 mi
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell LymphomaPhase 2<1 mi
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive SurgeryPhase 2<1 mi
A Study of a Vaccine in Combination With Beta-glucan in People With NeuroblastomaPhase 2<1 mi
A Study of Ruxolitinib and Duvelisib in People With LymphomaPhase 1<1 mi
A Study of CRD3874-SI in People With Solid TumorsPhase 1<1 mi
A Study of Deferoxamine (DFO) in People With Leptomeningeal MetastasisPhase 1<1 mi
A Study of Glofitamab and Lenalidomide in People With Mantle Cell LymphomaPhase 1<1 mi
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerPhase 3<1 mi
Post-op T-DM1 in HER-2+ Salivary Gland CarcinomasPhase 2<1 mi
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell TransplantPhase 2<1 mi
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck CancerPhase 1<1 mi
A Study Collecting Health Information to Understand and Prevent Gastric Cancer—<1 mi
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)Phase 1<1 mi
A Study of Botensilimab and Balstilimab for Rectal AdenocarcinomaPhase 2<1 mi
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity CancerPhase 2/3<1 mi
A Study of ERAS-601 in People With ChordomaPhase 1/2<1 mi
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)Phase 2<1 mi
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction CancerPhase 2<1 mi
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer—<1 mi
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)Phase 1/2<1 mi
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric CancerPhase 2<1 mi
Collection of Information to Better Understand Young Onset Colorectal Cancer—<1 mi
A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell LymphomaPhase 2<1 mi
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With SurgeryPhase 2<1 mi
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)N/A<1 mi
A Study of Tucatinib and Trastuzumab in People With Rectal CancerPhase 2<1 mi
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian CancerPhase 2<1 mi
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms—<1 mi
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin LymphomaPhase 2<1 mi
A Study of Questionnaires in Adolescents and Young Adults With Cancer—<1 mi
A Study of BV-AVD in People With Bulky Hodgkin LymphomaPhase 2<1 mi
A Study of ADCLEC.syn1 in People With Acute Myeloid LeukemiaPhase 1<1 mi
A Study of Ivonescimab in People With Endometrial and Cervical CancersPhase 2<1 mi
A Study of Surgical Techniques During CystectomyPhase 3<1 mi
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free HomeN/A<1 mi
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple MyelomaPhase 1<1 mi
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell LymphomaEarly 1<1 mi
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDACPhase 2<1 mi
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell TransplantationPhase 2<1 mi
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple MyelomaPhase 2<1 mi
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular LymphomaPhase 2<1 mi
Acupuncture for People Experiencing Period Loss Due to ChemotherapyPhase 2<1 mi
A Study of the Use of 3D Technology to Guide Head and Neck SurgeryN/A<1 mi
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationPhase 2<1 mi
A Music Therapy Study for Blood Cancer Survivors With Cognitive DifficultiesN/A<1 mi
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and ChemotherapyPhase 2<1 mi
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)N/A<1 mi
A Study of Avutometinib and Defactinib in People With Thyroid CancerPhase 2<1 mi
A Study of Tongue Strength and Endurance Using the Iowa Oral Performance Instrument (IOPI) Tongue Strength Trainer in People With Oral Tongue CanceN/A<1 mi
A Study of SER-155 to Treat Diarrhea in People on ImmunotherapyPhase 1<1 mi
Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal CancerPhase 2<1 mi
A Study of Herbal Supplements in Cancer Survivors With ConstipationN/A<1 mi
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell CarcinomaPhase 2<1 mi
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal CancersPhase 2<1 mi
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous LeukemiaPhase 1<1 mi
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerPhase 1<1 mi
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma—<1 mi
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic AlterationsPhase 2<1 mi
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial CancerPhase 2<1 mi
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate CancerPhase 2<1 mi
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC TrialPhase 2<1 mi
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell TransplantPhase 2<1 mi
COBRA: Cancer, Older Adults, Balance and Resistance ActivitiesN/A<1 mi
A Study of Pembrolizumab in People With Ultra-Rare SarcomasPhase 2<1 mi
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid LeukemiaPhase 1<1 mi
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary TractPhase 2<1 mi
A Study of Sotorasib in People With Brain TumorsPhase 1<1 mi
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard TreatmentPhase 1<1 mi
Genomic Profiling in Cancer Patients—<1 mi
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate CancerPhase 1/2<1 mi
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)Phase 2<1 mi
Ulixertinib in People With Histiocytic NeoplasmsPhase 2<1 mi
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur StudyPhase 3<1 mi
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)Phase 2<1 mi
A Study of Enfortumab Vedotin in People With Adenoid Cystic CarcinomaPhase 2<1 mi
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell TransplantPhase 2<1 mi
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)Phase 2<1 mi
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer—<1 mi
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG TherapyPhase 3<1 mi
A Study of Multiparametric Ultrasound Imaging MethodsN/A<1 mi
Germ Cell Tumor and Testicular Tumor DNA Registry—<1 mi
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)Phase 1<1 mi
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate CancerN/A<1 mi
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or LegPhase 2<1 mi
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial CancerEarly 1<1 mi
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by SurgeryPhase 2<1 mi
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat CancerPhase 2<1 mi
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Phase 2<1 mi
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell TransplantPhase 2<1 mi
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive SurgeryPhase 2<1 mi
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome PatientsPhase 2<1 mi
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal CancerPhase 3<1 mi
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck CancerPhase 2<1 mi
A Study of Meaning-Centered Psychotherapy for Caregivers to People With CancerN/A<1 mi
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentPhase 3<1 mi
A Study of 177Lu-PSMA-617 in People With GliomasPhase 1<1 mi
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromesPhase 1<1 mi
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders—<1 mi
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell CarcinomaPhase 2<1 mi
A Dietary Study for People With Multiple MyelomaN/A<1 mi
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)Phase 2<1 mi
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid LeukemiaPhase 2<1 mi
Study of eFT226 in Subjects With Selected Advanced Solid Tumor MalignanciesPhase 1/2<1 mi
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell TherapyPhase 2<1 mi
A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic CancerPhase 2<1 mi
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE TrialPhase 3<1 mi
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)Phase 2<1 mi
Using a Blood Test and Software Tool to Guide Treatment for Venous ThromboembolismN/A<1 mi
A Study of Response to Standard Treatment Before Surgery in People With Rectal CancerN/A<1 mi
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1Phase 2<1 mi
A Study of Pasireotide in People With ProlactinomaPhase 2<1 mi
A Study of Mirdametinib in Combination With Palbociclib in People With LiposarcomaPhase 1/2<1 mi
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)Phase 2<1 mi
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal CancerPhase 3<1 mi
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and HypogammaglobulinemiaPhase 2<1 mi
A Study of Intra-operative Imaging in Women With Ovarian CancerPhase 3<1 mi
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland CancersPhase 2<1 mi
A Study of Tarlatamab for People With Prostate CancerPhase 2<1 mi
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid LeukemiaPhase 2<1 mi
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsPhase 2<1 mi
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment—<1 mi
A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)Phase 2<1 mi
Impact of ICCAN on Cancer Treatment Completion and Quality of Life—<1 mi
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma—<1 mi
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell CarcinomaPhase 2<1 mi
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)Phase 1<1 mi
Collecting Information About Treatment Results for Patients With Cushing's Syndrome—<1 mi
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid TumorsPhase 2<1 mi
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With CancerN/A<1 mi
A Study of a Weight Loss Intervention in People With Endometrial CancerEarly 1<1 mi
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their CaregiversN/A<1 mi
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With SarcomaN/A<1 mi
A Study of Pembrolizumab and Cryoablation in People With Breast CancerPhase 1<1 mi
Factors Associated With Breast Cancer Risks and Outcomes—<1 mi
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations—<1 mi
A Study to Prevent and Improve Sexual Health Concerns for People With Breast CancerN/A<1 mi
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast CancerPhase 3<1 mi
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your JobN/A<1 mi
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer—<1 mi
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized TrialN/A<1 mi
A Study of SDX-7320 in Combination With Eribulin for People With Breast CancerPhase 2<1 mi
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast CancerPhase 2<1 mi
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast CancerPhase 2<1 mi
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast CancerPhase 2<1 mi
A Study of a Decision Tool for People Considering Breast Reconstruction SurgeryN/A<1 mi
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid TumorsPhase 2<1 mi
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast CancerPhase 3<1 mi
A Study on Pain After Breast ReconstructionN/A<1 mi
A Study of Revaree Plus in People With Breast CancerPhase 4<1 mi
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors—<1 mi
A Study of Blood Pressure Control During Cancer TreatmentPhase 2<1 mi
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain ControlPhase 3<1 mi
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast CancerN/A<1 mi
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing TumorsPhase 2<1 mi
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander PlacementPhase 4<1 mi
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma—<1 mi
A Study of Language Interpretation Solutions for People With Breast CancerN/A<1 mi
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) ProtocolPhase 4<1 mi
Lymphedema Surveillance Study—<1 mi
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast CancerPhase 1<1 mi
Study of Aerobic Training for People Receiving Chemotherapy for Breast CancerPhase 2<1 mi
A Registry for People With T-cell Lymphoma—<1 mi
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast CancerPhase 2<1 mi
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)—<1 mi
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell LymphomaPhase 2<1 mi
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast CancerPhase 1<1 mi
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer SurvivorsPhase 2<1 mi
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast CancerPhase 1/2<1 mi
A Study of Surgery and Radiotherapy in People With Breast CancerPhase 2<1 mi
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric CancerPhase 1<1 mi
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung CancerPhase 1/2<1 mi
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerPhase 1/2<1 mi
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung CancerPhase 2<1 mi
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueN/A<1 mi
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL ActivityPhase 2<1 mi
A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and ChestPhase 2<1 mi
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal MesotheliomaPhase 2<1 mi
Using Urine Samples to Identify Lung Cancer—<1 mi
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung CancerPhase 2<1 mi
A Study of Lung Cancer Screening in People With Unexplained Weight Loss—<1 mi
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With SurgeryPhase 2<1 mi
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the BrainPhase 2<1 mi
A Study of ZEN003694 in People With Squamous Cell Lung CancerPhase 2<1 mi
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.Phase 1<1 mi
A Study of Sacituzumab Govitecan in People With MesotheliomaPhase 2<1 mi
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsPhase 1<1 mi
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of DiseasePhase 2<1 mi
A Study of Hospital-at-Home for People Receiving TarlatamabN/A<1 mi
A Study of Tumor-Treating Fields (TTFields) in People With Lung AdenocarcinomaPhase 1<1 mi
A Study of Pembrolizumab and Radiation Therapy in People With MesotheliomaPhase 1<1 mi
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung DiseasePhase 2<1 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)Phase 2<1 mi
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung CancersPhase 2<1 mi
A Study of Valemetostat in Combination With Atezolizumab in People With Lung CancerPhase 1<1 mi
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the BrainPhase 2<1 mi
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer—<1 mi
A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung CancerPhase 1<1 mi
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM TrialPhase 3<1 mi
A Registry for People With Lung Cancer—<1 mi
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural MesotheliomaN/A<1 mi
A Study of Sotorasib in People With Non-Small Cell Lung CancerPhase 2<1 mi
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)Phase 3<1 mi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1Phase 3<1 mi
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal CancerPhase 2<1 mi
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)Phase 2<1 mi
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialPhase 3<1 mi
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical CarcinomaPhase 2<1 mi
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)Phase 2/3<1 mi
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsPhase 2/3<1 mi
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaPhase 3<1 mi
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyPhase 3<1 mi
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerPhase 3<1 mi
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)Phase 3<1 mi
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2Phase 3<1 mi
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaPhase 3<1 mi
A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)Phase 2<1 mi
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLPhase 2<1 mi
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerPhase 3<1 mi
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)Phase 3<1 mi
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast CancerPhase 1/2<1 mi
SLV-154 Treatment of Metastatic Solid TumorsPhase 1<1 mi
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation—<1 mi
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)Phase 1/2<1 mi
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid TumorsPhase 1<1 mi
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.N/A<1 mi
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingPhase 3<1 mi
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-NaïvePhase 1/2<1 mi
Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT TrialPhase 3<1 mi
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering MyelomaPhase 3<1 mi
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationPhase 3<1 mi
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients—<1 mi
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney CancerPhase 2<1 mi
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 2<1 mi
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)Phase 3<1 mi
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive ChemotherapyPhase 2<1 mi
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body—<1 mi
A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaPhase 2<1 mi
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLPhase 3<1 mi
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid TumorsPhase 1/2<1 mi
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing LossPhase 3<1 mi
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder CancerPhase 3<1 mi
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma PatientsPhase 3<1 mi
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AMLPhase 1<1 mi
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 1<1 mi
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple MyelomaPhase 1/2<1 mi
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell MalignanciesPhase 1/2<1 mi
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder CancerPhase 2<1 mi
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTPhase 2<1 mi
Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted TreatmentPhase 1<1 mi
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced CancersPhase 1/2<1 mi
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)Phase 3<1 mi
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)Phase 1/2<1 mi
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCTPhase 2<1 mi
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)Phase 2<1 mi
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 MutationPhase 1/2<1 mi
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaPhase 3<1 mi
Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)Phase 2<1 mi
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsPhase 3<1 mi
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative RhabdomyosarcomaPhase 3<1 mi
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract CancerPhase 3<1 mi
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult ParticipantsPhase 1<1 mi
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.Phase 1<1 mi
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)Phase 3<1 mi
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed OsteosarcomaPhase 2/3<1 mi
Study of TJ033721 (givastomig) in Subjects with Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)—<1 mi
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLPhase 2<1 mi
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 AlterationsPhase 1/2<1 mi
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer PatientsPhase 2<1 mi
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaPhase 3<1 mi
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto—<1 mi
A Long-term Study for Participants Previously Treated With Ciltacabtagene AutoleucelPhase 4<1 mi
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)Phase 1/2<1 mi
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform StudyPhase 2<1 mi
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies—<1 mi
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)Phase 3<1 mi
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received TreatmentPhase 1/2<1 mi
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic LeukemiaPhase 2<1 mi
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)Phase 3<1 mi
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)Phase 1/2<1 mi
Fabry Disease Registry & Pregnancy Sub-registry—<1 mi
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaPhase 2<1 mi
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerPhase 1<1 mi
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase InhibitionPhase 2<1 mi
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System LymphomaPhase 2<1 mi
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal CancerN/A<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2<1 mi
Abatacept in Immune Checkpoint Inhibitor MyocarditisPhase 3<1 mi
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable CancerPhase 1<1 mi
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerPhase 3<1 mi
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPhase 2<1 mi
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsPhase 1<1 mi
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrencePhase 3<1 mi
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerPhase 3<1 mi
Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic InstabilityPhase 2<1 mi
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast CancerPhase 1<1 mi
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic DiseasePhase 3<1 mi
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)Phase 3<1 mi
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerPhase 3<1 mi
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast CancerPhase 2<1 mi
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationPhase 3<1 mi
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H MutationPhase 1<1 mi
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Phase 2<1 mi
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)Phase 3<1 mi
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib TreatmentPhase 3<1 mi
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine TumorsPhase 1<1 mi
A Phase 1/1b Study of IAM1363 in HER2 CancersPhase 1<1 mi
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionPhase 1<1 mi
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsPhase 1/2<1 mi
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaPhase 3<1 mi
TTX-080 HLA-G Antagonist in Subjects With Advanced CancersPhase 1<1 mi
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 CirrhosisPhase 2<1 mi
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaPhase 3<1 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—<1 mi
Registry Study for Radiation Therapy Outcomes—<1 mi
Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy—<1 mi
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous MelanomaN/A<1 mi
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)Phase 1<1 mi
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects—<1 mi
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.Phase 3<1 mi
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCPhase 3<1 mi
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs—<1 mi
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3<1 mi
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell CarcinomaPhase 3<1 mi
PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2N/A<1 mi
Trial of Combined Obstetric Carrier Screening and Hereditary Cancer ScreeningN/A<1 mi
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple MyelomaPhase 3<1 mi
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation—<1 mi
Chatbot to Maximize Hereditary Cancer Genetic Risk AssessmentN/A<1 mi
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaPhase 3<1 mi
International Registry for Men With Advanced Prostate Cancer (IRONMAN)—<1 mi
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)Phase 3<1 mi
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate CancerPhase 1<1 mi
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix CancerN/A<1 mi
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)Phase 3<1 mi
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsN/A<1 mi
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)Phase 3<1 mi
ATEMPT 2.0: Adjuvant T-DM1 vs THPhase 2<1 mi
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast CancerPhase 2<1 mi
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical StudyN/A<1 mi
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint InhibitorPhase 3<1 mi
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung CancerPhase 3<1 mi
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerPhase 3<1 mi
Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C MutationPhase 2<1 mi
A Study of Sigvotatug Vedotin in Advanced Solid TumorsPhase 1<1 mi
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis FungoidesPhase 1<1 mi
A Study of BMS986365 in Combination With Degarelix in People With Prostate CancerPhase 2<1 mi
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)Phase 3<1 mi
Phase IIIb Study of Ribociclib + ET in Early Breast CancerPhase 3<1 mi
A Study of a Distress Screening and Referral Program in People With Recently Diagnosed CancerN/A<1 mi
An Acupuncture Study for Cancer Survivors With Joint PainN/A<1 mi
Novel Imaging Technique to Assess Gynecologic CancerPhase 1<1 mi
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated SarcomasPhase 3<1 mi
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical TrialsPhase 4<1 mi
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments—<1 mi
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian CancerPhase 3<1 mi
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate CancerN/A<1 mi
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)Phase 3<1 mi
Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical GastrojejunostomyN/A<1 mi
A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With Pancreatic CancerPhase 1<1 mi
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid TumorsPhase 1<1 mi
First in Human Study of IMGN151 in Recurrent Gynaecological CancersPhase 1<1 mi
A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 InactivationPhase 2<1 mi
Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic MalignanciesPhase 1/2<1 mi
A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer SurvivorsPhase 2<1 mi
Zanubrutinib and Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia (CLL) With Response-based ObinutuzumabPhase 2<1 mi
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia GravisPhase 1/2<1 mi
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate CancerN/A<1 mi
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2Phase 3<1 mi
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin LymphomaPhase 1/2<1 mi
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's LymphomaPhase 1/2<1 mi
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor MalignanciesPhase 1/2<1 mi
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorPhase 1/2<1 mi
Identification and Treatment Of Micrometastatic Disease in Stage III Colon CancerPhase 3<1 mi
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)Phase 3<1 mi
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and EpendymomaN/A<1 mi
Neurofibromatosis (NF) Registry Portal—<1 mi
Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic ChangesPhase 2<1 mi
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaPhase 1/2<1 mi
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma—<1 mi
Screening for AL Amyloidosis in Smoldering Multiple Myeloma—<1 mi
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid TumorsPhase 1<1 mi
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaPhase 2<1 mi
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair GenesPhase 1<1 mi
A Study of Avutometinib for People With Solid Tumor CancersPhase 1<1 mi
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive TherapyPhase 2<1 mi
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyPhase 2<1 mi
A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or RecurrencePhase 2<1 mi
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell LymphomaPhase 2<1 mi
An Extension Study for Patients Previously Enrolled in Studies With PelabresibPhase 3<1 mi
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)Phase 1<1 mi
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmsPhase 1<1 mi
A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerPhase 1/2<1 mi
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)Phase 2<1 mi
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions—<1 mi
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder CancerPhase 2<1 mi
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other TumorsPhase 1/2<1 mi
Tissue Collection for Drug Screening and Bioanalysis—<1 mi
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment RegimenPhase 3<1 mi
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced MalignanciesPhase 1/2<1 mi
Intent of Surgery for IPMN—<1 mi
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal MelanomaPhase 2/3<1 mi
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate CancerPhase 1<1 mi
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab AdizutecanPhase 2<1 mi
Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer ScreeningN/A<1 mi
Combination Therapy for the Treatment of Diffuse Midline GliomasPhase 2<1 mi
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related DiseasesPhase 1<1 mi
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related ValuesN/A<1 mi
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T TherapyPhase 2<1 mi
Imetelstat Combinations in Relapsed AMLPhase 1<1 mi
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid TumorsPhase 1/2<1 mi
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia GravisPhase 3<1 mi
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid TumorsPhase 1/2<1 mi
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)N/A<1 mi
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) AmyloidosisPhase 1/2<1 mi
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube CancerPhase 3<1 mi
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerPhase 3<1 mi
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone AcetatePhase 2<1 mi
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell CarcinomaPhase 3<1 mi
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerPhase 3<1 mi
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerPhase 2<1 mi
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer—<1 mi
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically RemovedPhase 1/2<1 mi
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)Phase 1<1 mi
Pacritinib in CMMLPhase 1/2<1 mi
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)Phase 1<1 mi
Ablative Therapy in the Management of Prostate Cancer—<1 mi
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic CancerPhase 1/2<1 mi
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)Phase 1/2<1 mi
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid TumorsPhase 1<1 mi
Safety and Tolerability Study of GIM-531 in Advanced Solid TumorsPhase 1/2<1 mi
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After ImmunotherapyPhase 2/3<1 mi
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1Phase 2/3<1 mi
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic CancerPhase 1<1 mi
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer SurvivorsN/A<1 mi
Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan PharmacokineticsPhase 1<1 mi
Characterization of Hyperpolarized Pyruvate MRI ReproducibilityN/A<1 mi
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (RemeMG)Phase 3<1 mi
Trastuzumab Deruxtecan (T-DXd) for People With Brain CancerPhase 2<1 mi
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions—<1 mi
Pancreas Registry and High Risk Registry—<1 mi
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors—<1 mi
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerPhase 1/2<1 mi
Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory NervesN/A<1 mi
Precision Medicine Study—<1 mi
European Prospective Investigation Into Childhood Cancer—<1 mi
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib TherapyPhase 3<1 mi
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer—<1 mi
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AMLPhase 1<1 mi
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaPhase 2<1 mi
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and RevumenibPhase 1/2<1 mi
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBMPhase 1/2<1 mi
The SUGAR Study; SBRT and Relugolix) for Prostate CancerPhase 2<1 mi
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsPhase 1/2<1 mi
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCLPhase 3<1 mi
Clinical Trial of Approaches to Prostate Cancer SurgeryN/A<1 mi
(Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisPhase 2<1 mi
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 MutationPhase 1<1 mi
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)Phase 1<1 mi
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal CancerPhase 3<1 mi
A New Psychotherapy Intervention for Older Cancer PatientsN/A<1 mi
Anti-GD2 ADC M3554 in Advanced Solid TumorsPhase 1<1 mi
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid TumorsPhase 1<1 mi
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer PainN/A<1 mi
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)Phase 1/2<1 mi
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)Phase 2<1 mi
Psychotherapy Intervention for Latinos With Adv CancerN/A<1 mi
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaPhase 1<1 mi
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene AlterationsPhase 2<1 mi
Stereotactic MRI-guided Focused Ultrasound MesencephalotomyN/A<1 mi
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular LymphomaPhase 3<1 mi
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2Phase 3<1 mi
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid TumorsPhase 1/2<1 mi
Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal CarcinomaPhase 2<1 mi
Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic CancersN/A<1 mi
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 3<1 mi
A Study of Time-Restricted Eating in Childhood Cancer SurvivorsN/A<1 mi
Neoadjuvant Darovasertib in Primary Uveal MelanomaPhase 3<1 mi
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial CarcinomaPhase 1<1 mi
Tazemetostat and Mosunetuzumab in Untreated Follicular LymphomaPhase 2<1 mi
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell MalignanciesPhase 1<1 mi
Efficacy and Safety of the CG-100 Intraluminal Bypass DeviceN/A<1 mi
Concurrent XRD-0394 With Radiation Therapy for High Grade GliomasEarly 1<1 mi
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials—<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)Phase 1/2<1 mi
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing SarcomaPhase 1/2<1 mi
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone MarrowPhase 2<1 mi
Longitudinal Oral Microbiome Sampling for BE—<1 mi
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease—<1 mi
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort StudyN/A<1 mi
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaPhase 1<1 mi
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCPhase 3<1 mi
IVIG for Infection Prevention After CAR-T-Cell TherapyPhase 2<1 mi
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)Phase 3<1 mi
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)—<1 mi
New MRI Biomarkers in Head and Neck Cancers—<1 mi
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline TherapyPhase 2<1 mi
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid LeukemiaPhase 1<1 mi
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal CancerPhase 1/2<1 mi
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3Phase 1<1 mi
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active SurveillancePhase 2<1 mi
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue SarcomaPhase 2<1 mi
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)Phase 1/2<1 mi
FITting Non-invasive Tests in Lynch Syndrome Surveillance—<1 mi
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia IIPhase 1/2<1 mi
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin LymphomaPhase 1<1 mi
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid TumorsPhase 1/2<1 mi
Simple Bone Cysts in KidsPhase 3<1 mi
Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin LymphomaPhase 1<1 mi
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With NeuroblastomaPhase 2<1 mi
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 SystemPhase 1/2<1 mi
Phase 1, Open-label, Dose-escalation Trial with CD38-SADA:177 Lu-DOTA Drug Complex in Subjects with Relapsed or Refractory Non-Hodgkin LymphomaPhase 1<1 mi
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic ChemotherapyPhase 2<1 mi
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated GlioblastomaPhase 3<1 mi
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid TumorsN/A<1 mi
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)Phase 3<1 mi
177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine TumorsPhase 1<1 mi
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaPhase 1/2<1 mi
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic LeukemiaPhase 2<1 mi
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder CancerPhase 1/2<1 mi
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic SyndromesPhase 1<1 mi
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia—<1 mi
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral NeuropathyPhase 3<1 mi
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors—<1 mi
Brentuximab Vedotin in Early Stage Hodgkin LymphomaPhase 3<1 mi
RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study—<1 mi
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal CancerPhase 2<1 mi
A Phase I Study of SIM0505 in Participants With Advanced Solid TumorsPhase 1<1 mi
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including SarcomasPhase 1<1 mi
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple MyelomaPhase 2<1 mi
Prospective Study to Assess a Diagnostic Aid for Cancer—<1 mi
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)Phase 2<1 mi
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)—<1 mi
Neuroblastoma Maintenance Therapy TrialPhase 2<1 mi
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)Phase 2<1 mi
Tumor Microenvironment Analysis of Prostate Cancer Metastasis—<1 mi
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)Phase 1/2<1 mi
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and LenalidomidePhase 3<1 mi
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care TreatmentsPhase 1<1 mi
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory LymphomaPhase 1<1 mi
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate CancerPhase 3<1 mi
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic MastocytosisPhase 2/3<1 mi
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid TumorsPhase 1/2<1 mi
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)Phase 2/3<1 mi
Early Feeding After Oral Cavity ReconstructionN/A<1 mi
Study of IBI3020 Treatment in Participants With Late-Stage Solid TumorsPhase 1<1 mi
A Study of ZL-1310 in Participants With Selected Solid TumorsPhase 1/2<1 mi
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)Phase 1<1 mi
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCLN/A<1 mi
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain CancerPhase 1<1 mi
WATER IV Prostate CancerN/A<1 mi
Actinium Therapy for Late-stage Aggressive SarcomasPhase 1<1 mi
Study of CAR-T Therapy in Older Patients—<1 mi
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin LymphomaPhase 1/2<1 mi
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin OintmentPhase 1/2<1 mi
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to TherapyPhase 1<1 mi
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic LeukemiaPhase 3<1 mi
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity TrialPhase 2<1 mi
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid TumorsPhase 2<1 mi
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder CancerPhase 1<1 mi
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPhase 1/2<1 mi
Study of AZD0754 in Participants With Metastatic Prostate CancerPhase 1/2<1 mi
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid TumorsPhase 1/2<1 mi
A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)Phase 1/2<1 mi
Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the BladderPhase 1/2<1 mi
Concurrent Azeliragon With Craniospinal IrradiationPhase 1<1 mi
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant DisordersPhase 2<1 mi
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)Phase 1/2<1 mi
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade GliomaN/A<1 mi
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian CancerPhase 1<1 mi
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALLPhase 2<1 mi
Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATEPhase 4<1 mi
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor CancerPhase 1/2<1 mi
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GlioblastomaN/A<1 mi
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness—<1 mi
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate CancerPhase 1<1 mi
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)Phase 3<1 mi
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate CancerPhase 2<1 mi
Tislelizumab in People With Colorectal CancerPhase 2<1 mi
A First-in-Human Study of YL217 in Patients With Advanced Solid TumorsPhase 1<1 mi
A Study of ASP3082 in Adults With Advanced Solid TumorsPhase 1<1 mi
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's TransformationPhase 2<1 mi
Excision of Lymph Node Trial (EXCILYNT) (Mel69)N/A<1 mi
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)Phase 2<1 mi
Study of SGR-1505 in Mature B-Cell NeoplasmsPhase 1<1 mi
A Study of CTD402 in T-ALL/LBL PatientsPhase 1/2<1 mi
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric GliomasPhase 1/2<1 mi
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Phase 2<1 mi
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid TumorsPhase 1<1 mi
Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-TransplantPhase 1/2<1 mi
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NETPhase 3<1 mi
DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaPhase 1<1 mi
First-in-Human Study of ADCE-D01 in Soft Tissue SarcomaPhase 1/2<1 mi
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsPhase 2/3<1 mi
Registry for Esophageal and Gastroesophageal Junction Cancer—<1 mi
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate CancerPhase 2<1 mi
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia GravisPhase 3<1 mi
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic CarcinomaPhase 1/2<1 mi
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCPhase 3<1 mi
A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)Phase 1/2<1 mi
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)Phase 2<1 mi
MB-105 in Patients With CD5 Positive T-cell LymphomaPhase 2<1 mi
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's LymphomaPhase 1/2<1 mi
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)Phase 2<1 mi
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or ParagangliomaPhase 2<1 mi
Adaptive Radiation in Anal CancerN/A<1 mi
Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early RelapsePhase 2<1 mi
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.Phase 1/2<1 mi
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)Phase 1<1 mi
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)—<1 mi
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA TherapyPhase 3<1 mi
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell LymphomaPhase 2<1 mi
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerPhase 2<1 mi
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma—<1 mi
CD4CAR for CD4+ Leukemia and LymphomaPhase 1<1 mi
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid CarcinomaPhase 1<1 mi
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic CancersPhase 1/2<1 mi
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)Phase 1/2<1 mi
An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid TumorsPhase 1<1 mi
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 TabletsPhase 1<1 mi
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.Phase 3<1 mi
Blue Light Cystoscopy With Cysview® Registry—<1 mi
Pancreatic Cancer Early Detection Consortium—<1 mi
Gadopiclenol in Contrast Enhanced MRI of the ProstatePhase 4<1 mi
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)Phase 1/2<1 mi
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer—<1 mi
Neurocutaneous Melanocytosis Registry—<1 mi
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.Phase 1/2<1 mi
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal MelanomaPhase 3<1 mi
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsPhase 1<1 mi
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)Phase 1<1 mi
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic AlterationsPhase 2<1 mi
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal CancerPhase 2<1 mi
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid TumorsPhase 1/2<1 mi
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)Phase 1/2<1 mi
Selinexor and Backbone Treatments of Multiple Myeloma PatientsPhase 1/2<1 mi
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)Phase 3<1 mi
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid TumorsPhase 1<1 mi
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Phase 3<1 mi
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or UbamatamabPhase 1/2<1 mi
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid TumorsPhase 1/2<1 mi
Study of Canakinumab in Patients With MyelofibrosisPhase 2<1 mi
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate CancerPhase 1<1 mi
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.Phase 2<1 mi
Primary Tumor Research and Outcomes Network—<1 mi
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
Evaluation of Grief Therapy Approaches for Bereaved ParentsN/A<1 mi
Study of a Communication Training Intervention for Large B-Cell Lymphoma ProvidersN/A<1 mi
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaPhase 1<1 mi
Colonoscopy vs Stool Testing for Older Adults With Colon PolypsN/A<1 mi
Adoptive Cell Therapy Long-term Follow-up (LTFU) StudyPhase 1<1 mi
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaPhase 2<1 mi
FOG-001 in Locally Advanced or Metastatic Solid TumorsPhase 1/2<1 mi
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin MalignanciesPhase 1/2<1 mi
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaPhase 2<1 mi
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer—<1 mi
PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound—<1 mi
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System—<1 mi
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher RiskN/A<1 mi
Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.Phase 1/2<1 mi
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialPhase 2/3<1 mi
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid LeukemiaPhase 1/2<1 mi
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal AdenocarcinomaPhase 2<1 mi
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815Phase 1<1 mi
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)Phase 1<1 mi
A Study of YL201 in Patients With Advanced Solid TumorsPhase 1/2<1 mi
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)Phase 2<1 mi
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaPhase 2/3<1 mi
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial CancerPhase 2<1 mi
Universal Genetic Testing for Cancer Risk ReductionN/A<1 mi
Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous MetastasesPhase 1<1 mi
Lurbinectedin in FET-Fused TumorsPhase 1/2<1 mi
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)Phase 1<1 mi
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid TumorsPhase 1<1 mi
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid TumorsPhase 1<1 mi
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsPhase 1<1 mi
RFA for Superficial LipomasN/A<1 mi
Mobile Health Application (PACT) to Improve Engagement in Advance Care PlanningN/A<1 mi
SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic MalformationsPhase 3<1 mi
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid TumorsPhase 1<1 mi
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic LeukemiaPhase 2<1 mi
Fitness and Nutrition in GliomaN/A<1 mi
Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)N/A<1 mi
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaPhase 1<1 mi
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary TractPhase 3<1 mi
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple MyelomaPhase 3<1 mi
Leading in MPNs Beyond Ruxolitinib in Combo With T-RegsPhase 1<1 mi
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin CancerPhase 1<1 mi
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors—<1 mi
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric CancerPhase 3<1 mi
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban PopulationsN/A<1 mi
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI DiscontinuationPhase 2<1 mi
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionPhase 2<1 mi
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic AdenocarcinomaPhase 2<1 mi
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant TumorsPhase 1/2<1 mi
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment—<1 mi
PediRISE FeasibilityN/A<1 mi
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)Phase 2<1 mi
Amping up With PemJAKPhase 2<1 mi
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple MyelomaPhase 1/2<1 mi
ACTengine® IMA203 Combined With mRNA-4203Phase 1<1 mi
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)Phase 2/3<1 mi
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) AmyloidosisPhase 1<1 mi
Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionPhase 1/2<1 mi
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX OverexpressionPhase 1/2<1 mi
A Study of EP0031 in Patients With Advanced RET-altered MalignanciesPhase 1/2<1 mi
Cryotherapy & OxaliplatinN/A<1 mi
Study of SGR-3515 In Participants With Advanced Solid Tumors.Phase 1<1 mi
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial CancerPhase 1/2<1 mi
Chinese American Cancer Survivors Writing StudyN/A<1 mi
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck CancerPhase 3<1 mi
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed GlioblastomaPhase 3<1 mi
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable TreatmentPhase 3<1 mi
A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid TumorsPhase 1<1 mi
A Study of CHS-114 in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsPhase 1<1 mi
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic AdenocarcinomaPhase 2<1 mi
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete RemissionPhase 2<1 mi
Trial of Ixazomib for Kaposi SarcomaPhase 2<1 mi
A Study to Evaluate INCA035784 in Participants With Myeloproliferative NeoplasmsPhase 1<1 mi
Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)Phase 1<1 mi
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 1<1 mi
Psilocybin Therapy in Advanced CancerPhase 2/3<1 mi
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted ChemotherapyPhase 2<1 mi
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic MalignanciesPhase 1/2<1 mi
Cabozantinib for Patients With Recurrent or Progressive MeningiomaPhase 2<1 mi
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell LymphomaPhase 1<1 mi
Photopheresis in Early-stage Mycosis FungoidesPhase 2<1 mi
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromePhase 1<1 mi
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial CarcinomaPhase 2/3<1 mi
Chronic CED of TPT for Recurrent Malignant GliomaPhase 1<1 mi
Teclistamab-Daratumumab in AL AmyloidosisPhase 2<1 mi
A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative NeoplasmsPhase 1<1 mi
Testing Gene PilotLX With Latinx Cancer PatientsN/A<1 mi
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic CancerPhase 2/3<1 mi
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin LymphomasPhase 1/2<1 mi
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After TreatmentPhase 1<1 mi
A First-in-Human Trial of DS3790a in Participants With Hematological MalignanciesPhase 1/2<1 mi
Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell CancerPhase 2<1 mi
Limited-duration TeclistamabPhase 2<1 mi
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)Phase 1<1 mi
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsPhase 2<1 mi
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2Phase 1<1 mi
Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid TumorsPhase 1/2<1 mi
The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)Phase 2<1 mi
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)Phase 2<1 mi
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid TumorsPhase 1<1 mi
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade DysplasiaN/A<1 mi
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid TumorsPhase 1<1 mi
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical TrialsPhase 3<1 mi
Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRCPhase 1/2<1 mi
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaPhase 2<1 mi
Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal FunctionPhase 2<1 mi
A Study of TLN-254 in Participants With Relapsed or Refractory T-cell LymphomaPhase 1<1 mi
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell TransplantationPhase 3<1 mi
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid LeukemiaPhase 1/2<1 mi
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell SarcomaPhase 2<1 mi
A Multi Center Study of Sexual Toxicities After Radiotherapy—<1 mi
A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)Phase 1<1 mi
Personalized Models for Cancer Research—<1 mi
Study to Evaluate VT3989 in Patients With Metastatic Solid TumorsPhase 1/2<1 mi
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)Phase 3<1 mi
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple MyelomaPhase 1/2<1 mi
NYC Cancer Outreach Network in Neighborhoods for Equity and Community TranslationN/A<1 mi
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple MyelomaPhase 1<1 mi
TLN-372 in Advanced KRAS Mutant Solid TumorsPhase 1<1 mi
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 SystemPhase 1/2<1 mi
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPhase 2<1 mi
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon CancerPhase 3<1 mi
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerPhase 3<1 mi
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerPhase 3<1 mi
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic LymphomasPhase 1/2<1 mi
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary DiversionN/A<1 mi
A Study of ZN-c3 in Patients With Ovarian CancerPhase 1<1 mi
A Safety Study of SEA-CD70 in Patients With Myeloid MalignanciesPhase 1<1 mi
A Study of Changes to Prostate ProceduresPhase 3<1 mi
Comprehensive Assessment of Cancer Theranostic ResponseN/A<1 mi
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX GenesPhase 2<1 mi
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate CancerPhase 2<1 mi
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome—<1 mi
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCCPhase 2/3<1 mi
Study of How People Make Decisions About Prostate Cancer Risk—<1 mi
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple MyelomaPhase 1/2<1 mi
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)Phase 3<1 mi
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid TumorsPhase 1<1 mi
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) PirtobrutinibPhase 4<1 mi
Retrospective Review of Esophageal Cancer at MSKCC—<1 mi
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor—<1 mi
FUS Etoposide for DMGPhase 1<1 mi
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerPhase 3<1 mi
A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid LeukemiasPhase 1<1 mi
A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer TreatmentN/A<1 mi
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromePhase 1<1 mi
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin LymphomaPhase 2<1 mi
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction CancerPhase 3<1 mi
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)Phase 1/2<1 mi
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial CancerPhase 1/2<1 mi
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid TumorsPhase 1<1 mi
Avutometinib and Defactinib in Diffuse Gastric CancerPhase 2<1 mi
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV MelanomaPhase 2<1 mi
Psychotherapy Intervention for Latinos With Advanced CancerN/A<1 mi
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)Phase 1/2<1 mi
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal CancerPhase 3<1 mi
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple MyelomaPhase 1<1 mi
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode SystemN/A<1 mi
Environmental Factors and Thyroid Cancer—<1 mi
Tissue Repository: CTCL Collection Protocol—<1 mi
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid TumorsPhase 1<1 mi
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed GlioblastomaPhase 1/2<1 mi
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided RadiotherapyN/A<1 mi
Investigations of Reproductive Cancers in Women—<1 mi
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)Phase 3<1 mi
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)Phase 2<1 mi
Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint InhibitorsPhase 1/2<1 mi
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers—<1 mi
First in Human Study of TORL-1-23 in Participants With Advanced CancerPhase 1<1 mi
Carboplatin or Olaparib for BRcA Deficient Prostate CancerPhase 2<1 mi
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancErN/A<1 mi
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active SurveillancePhase 2<1 mi
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerPhase 2<1 mi
A Study of MGC028 in Participants With Advanced Solid TumorsPhase 1<1 mi
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian CancerPhase 2<1 mi
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPALPhase 1<1 mi
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple MyelomaPhase 1<1 mi
MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) TrialPhase 2<1 mi
Pleuroscopy First Versus Thoracentesis First in Patients With Suspected Malignant Pleural EffusionsN/A<1 mi
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)Phase 3<1 mi
A Study of CBX-250 in Participants With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaPhase 1<1 mi
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell MalignanciesPhase 1<1 mi
ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLCPhase 1<1 mi
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy—<1 mi
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCCPhase 2<1 mi
The Ambient Light Multiple Myeloma StudyN/A<1 mi
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal TumorsPhase 1<1 mi
Mechanisms of Resistance to PSMA Radioligand Therapy—<1 mi
A Study of CS5001 in Patients With Advanced Solid Tumors and LymphomasPhase 1<1 mi
Cord Blood Transplant in Adults With Blood CancersPhase 2<1 mi
Surgical Pembro +/- Olaparib w TMZ for rGBMPhase 2<1 mi
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)Phase 1/2<1 mi
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)Phase 1/2<1 mi
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate CancerPhase 2/3<1 mi
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and LymphomaPhase 1/2<1 mi
R-MVST Cells for Treatment of Viral Infections in Children and Young AdultsPhase 1<1 mi
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesPhase 1<1 mi
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBMPhase 3<1 mi
Screening Women With Prior HPV for Anal NeoplasiaN/A<1 mi
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)Phase 1<1 mi
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American PatientsPhase 2<1 mi
CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic CancerPhase 1<1 mi
A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem TransplantationPhase 1<1 mi
US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid MalignanciesPhase 1/2<1 mi
Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant GliomaPhase 1<1 mi
Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCTPhase 1/2<1 mi
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous PolypsN/A<1 mi
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy SpecimenN/A<1 mi
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple MyelomaPhase 1<1 mi
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AAPhase 1/2<1 mi
Observing People With Desmoid-Type Fibromatosis—<1 mi
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)Phase 3<1 mi
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)Phase 1/2<1 mi
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadPhase 2<1 mi
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck CancerPhase 3<1 mi
A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic CancerPhase 1/2<1 mi
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)Phase 2<1 mi
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated GliomaPhase 1/2<1 mi
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)Phase 1/2<1 mi
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid LeukemiaPhase 1<1 mi
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)Phase 1/2<1 mi
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate CancerPhase 2<1 mi
A Study to Evaluate Preventive Treatments for Talquetamab-related Oral ToxicityPhase 2<1 mi
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBMPhase 1<1 mi
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated DiseasesPhase 2<1 mi
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesPhase 1<1 mi
First-in-Human Trial of DS-2243a in Participants With Advanced Solid TumorsPhase 1<1 mi
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantPhase 2/3<1 mi
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)Phase 1/2<1 mi
Precision-Based Genomics in Prostate Cancer—<1 mi
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue SarcomaPhase 1/2<1 mi
A Phase 3 Study of Ersodetug in Patients With Tumor HyperinsulinismPhase 3<1 mi
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate CancerPhase 2<1 mi
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBCPhase 2<1 mi
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple MyelomaPhase 1<1 mi
A Study of ASP1002 in Adults for Treatment of Solid TumorsPhase 1<1 mi
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic PhasePhase 2<1 mi
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic LeukemiaPhase 1/2<1 mi
A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell MalignanciesPhase 1/2<1 mi
Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder CancerPhase 2<1 mi
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)Phase 3<1 mi
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)Phase 2/3<1 mi
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic CancerPhase 2<1 mi
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate CancerPhase 2<1 mi
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study—<1 mi
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk FactorsN/A<1 mi
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)—<1 mi
SPEARHEAD-3 Pediatric StudyPhase 1/2<1 mi
Pan Tumor Rollover StudyPhase 2<1 mi
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder CancerPhase 3<1 mi
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid TumorsPhase 1/2<1 mi
A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell TransplantPhase 1<1 mi
Tovorafenib for Treatment of Craniopharyngioma in Children and Young AdultsPhase 2<1 mi
Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell CarcinomaEarly 1<1 mi
A Study of Tooth Erosion in People With Esophagogastric CancerN/A<1 mi
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract CancerPhase 3<1 mi
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce RecurrencePhase 2<1 mi
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol—<1 mi
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell TumoursPhase 3<1 mi
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS TumorsPhase 1/2<1 mi
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical CarcinomaPhase 2<1 mi
Radiofrequency Ablation Study in LatinX PatientsN/A<1 mi
Metastatic Leiomyosarcoma Biomarker Protocol—<1 mi
Asciminib Roll-over StudyPhase 4<1 mi
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaEarly 1<1 mi
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)Phase 2<1 mi
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or AstrocytomaPhase 1<1 mi
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas—<1 mi
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical ProstatectomyPhase 3<1 mi
Advanced Diffusion Imaging in Renal Cancer PatientsN/A<1 mi
Decision Aid (DA) for Renal PatientsN/A<1 mi
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With CancerPhase 2<1 mi
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid TumorsPhase 1<1 mi
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable CancersPhase 1<1 mi
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)Phase 1<1 mi
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)Phase 1/2<1 mi
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.Phase 3<1 mi
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDSPhase 1<1 mi
Pembrolizumab, Ibrutinib and Rituximab in PCNSLPhase 1/2<1 mi
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Phase 1<1 mi
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaPhase 1/2<1 mi
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple MyelomaPhase 1/2<1 mi
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsPhase 3<1 mi
Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar CarcinomaPhase 1/2<1 mi
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) StudyPhase 3<1 mi
A Study to Evaluate Efficacy and Safety of Ciltacabtagene AutoleucelPhase 2<1 mi
A Study of DaratumumabPhase 3<1 mi
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma PatientsPhase 2<1 mi
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to TreatmentPhase 2<1 mi
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerPhase 2/3<1 mi
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic CancerN/A<1 mi
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia VeraPhase 3<1 mi
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.Phase 4<1 mi
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and ParagangliomaPhase 2<1 mi
Epco, Zanu, Ritux for R/R FL or MZLPhase 2<1 mi
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)Phase 3<1 mi
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)Phase 2<1 mi
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal TherapyPhase 1/2<1 mi
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)Phase 3<1 mi
Cryopreservation of Ovarian TissueN/A<1 mi
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerPhase 3<1 mi
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial CancerPhase 2<1 mi
An Acupuncture Study for People At High Risk for SepsisPhase 2<1 mi
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With CancerPhase 1<1 mi
Study of NXC-201 CAR-T in Patients With Light Chain (AL) AmyloidosisPhase 1/2<1 mi
Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients—<1 mi
Changes Associated With H. Pylori and Gastric Carcinogenesis—<1 mi
Study of ORIC-944 in Patients With Metastatic Prostate CancerPhase 1<1 mi
Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and ProvidersN/A<1 mi
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate CancerPhase 1<1 mi
Zanubrutinib, Obinutuzumab, and Sonrotoclax in Previously Untreated Patients With CLL or SLLPhase 2<1 mi
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction—<1 mi
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell CarcinomaPhase 3<1 mi
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOAPhase 2<1 mi
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic SyndromePhase 1<1 mi
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis—<1 mi
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid TumorsPhase 1<1 mi
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell LymphomaPhase 1<1 mi
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.Phase 1/2<1 mi
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic MalignanciesPhase 1/2<1 mi
Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell LymphomaPhase 2<1 mi
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate TreatmentPhase 3<1 mi
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)Phase 1<1 mi
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)Phase 1<1 mi
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated LiposarcomaPhase 1<1 mi
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialPhase 2<1 mi
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)Phase 3<1 mi
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma SubjectsPhase 1<1 mi
Avapritinib With Decitabine in Patients With SM-AHNPhase 1<1 mi
Childhood Cancer Survivor Study—<1 mi
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)Phase 3<1 mi
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 AlterationsPhase 2<1 mi
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple MyelomaPhase 1<1 mi
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma—<1 mi
International Rare Histiocytic Disorders Registry (IRHDR)—<1 mi
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer SurgeryN/A<1 mi
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)Phase 3<1 mi
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell MalignanciesPhase 1/2<1 mi
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study—<1 mi
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid LeukemiaPhase 1/2<1 mi
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment—<1 mi
A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple MyelomaPhase 1/2<1 mi
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal CancerPhase 4<1 mi
Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative NeoplasmPhase 1<1 mi
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies—<1 mi
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesPhase 1<1 mi
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)Phase 3<1 mi
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin LymphomaPhase 4<1 mi
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerPhase 1<1 mi
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Phase 2<1 mi
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid MalignanciesPhase 1<1 mi
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PETEarly 1<1 mi
Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors—<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; CarfilzomibPhase 1/2<1 mi
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)Phase 2<1 mi
Walnuts and Colon HealthN/A<1 mi
Sequential Therapy in Multiple Myeloma Guided by MRD AssessmentsPhase 2<1 mi
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AMLPhase 3<1 mi
Food and Microbiome Longitudinal Investigation (FAMiLI)—<1 mi
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1Phase 2<1 mi
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian CancerPhase 1/2<1 mi
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 MutationPhase 1/2<1 mi
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate CancerPhase 1<1 mi
MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMMPhase 2<1 mi
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPERPhase 2<1 mi
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell LymphomaPhase 3<1 mi
Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin LymphomaPhase 1/2<1 mi
Retinoblastoma Phase II Expanded Access Clinical TrialPhase 2<1 mi
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)Phase 3<1 mi
Study of REM-422 in Patients With AML or Higher Risk MDSPhase 1<1 mi
QTX3034 in Patients With KRAS G12D MutationPhase 1<1 mi
R-MVST Cells for Treatment of Viral InfectionsPhase 1<1 mi
A Study of Emapalumab for Pediatric Aplastic AnemiaPhase 2<1 mi
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With CancerPhase 3<1 mi
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)Phase 3<1 mi
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsPhase 1/2<1 mi
Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)N/A<1 mi
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCsN/A<1 mi
A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell LymphomasPhase 1/2<1 mi
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)Phase 1<1 mi
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALLPhase 1/2<1 mi
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)—<1 mi
Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT StudyPhase 2<1 mi
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous MelanomaPhase 3<1 mi
A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid TumorsPhase 1/2<1 mi
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian CancerPhase 3<1 mi
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)Phase 3<1 mi
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing SurveillanceN/A<1 mi
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) CancersPhase 1/2<1 mi
DALY II USA/ MB-CART2019.1 for DLBCLPhase 2<1 mi
Upright MRI for Prostate Cancer Screening—<1 mi
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic LeukemiaPhase 1<1 mi
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsPhase 1/2<1 mi
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell CarcinomaPhase 1<1 mi
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple MyelomaN/A<1 mi
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsPhase 1<1 mi
Two Fraction Prostate SBRT With DIL SIBPhase 1<1 mi
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)Phase 1<1 mi
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate CancerPhase 1<1 mi
A Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid TumorsPhase 1<1 mi
Collection and Storage of Tissue and Blood Samples From Patients With Cancer—<1 mi
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate CancerPhase 1<1 mi
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic LeukaemiaPhase 1/2<1 mi
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerPhase 1/2<1 mi
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple MyelomaPhase 1/2<1 mi
A Study of 177Lu-FAP-2286 in Advanced Solid TumorsPhase 1/2<1 mi
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma PatientsPhase 3<1 mi
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell LymphomasPhase 1<1 mi
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE TrialPhase 3<1 mi
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort—<1 mi
A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)Phase 1<1 mi
A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)Phase 1<1 mi
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)Phase 2<1 mi
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior ImmunotherapyPhase 1<1 mi
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)N/A<1 mi
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children—<1 mi
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer SurvivorsPhase 4<1 mi
TSC Biosample Repository and Natural History Database—<1 mi
NYSCF Scientific Discovery Biobank—<1 mi
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Phase 1<1 mi
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersPhase 1<1 mi
The Cancer of the Pancreas Screening-5 CAPS5)StudyPhase 3<1 mi
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsPhase 1<1 mi
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesPhase 1/2<1 mi
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyPhase 3<1 mi
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast CancerPhase 1<1 mi
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesPhase 1/2<1 mi
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationPhase 1<1 mi
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients—<1 mi
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast CancerPhase 1<1 mi
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast CancerPhase 3<1 mi
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationPhase 1/2<1 mi
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)—<1 mi
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialPhase 1<1 mi
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before SurgeryN/A<1 mi
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast CancerPhase 1<1 mi
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical TrialPhase 2<1 mi
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.Phase 1/2<1 mi
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid TumorsPhase 1<1 mi
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles—<1 mi
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton TherapyPhase 3<1 mi
Breast Elasticity Imaging During Neoadjuvant ChemotherapyN/A<1 mi
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)Phase 3<1 mi
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast CancerN/A<1 mi
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPhase 2<1 mi
IMPACT Trial: Intervention to iMProve AdherenCe EquitablyN/A<1 mi
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)Phase 1<1 mi
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated TumorsN/A<1 mi
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast CancerPhase 1<1 mi
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast CancerPhase 2<1 mi
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Phase 3<1 mi
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense BreastsN/A<1 mi
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain MetastasesPhase 1/2<1 mi
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsPhase 3<1 mi
A Study of LY4257496 in Participants With Cancer (OMNIRAY)Phase 1<1 mi
Two Versus One Week Breast Radiotherapy (RT)Phase 3<1 mi
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)N/A<1 mi
A Study of XMT-1660 in Participants With Solid TumorsPhase 1<1 mi
Combined Immunotherapies in Metastatic ER+ Breast CancerPhase 2<1 mi
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast CancerPhase 3<1 mi
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)N/A<1 mi
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania—<1 mi
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients—<1 mi
First in Human Study of TUB-030 in Patients With Advanced Solid TumorsPhase 1/2<1 mi
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsPhase 1/2<1 mi
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has SpreadPhase 1/2<1 mi
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast CancerN/A<1 mi
Optimizing Surgical Decisions in Young Adults With Breast CancerN/A<1 mi
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)Phase 2/3<1 mi
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerPhase 2<1 mi
Study of INCB123667 in Subjects With Advanced Solid TumorsPhase 1<1 mi
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You—<1 mi
Study of Zelenectide Pevedotin in Participants With Advanced Breast CancerPhase 2<1 mi
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast CancerPhase 1/2<1 mi
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)N/A<1 mi
Treatment of Breast Fibroadenoma Targeted Tissue With HIFUN/A<1 mi
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast CancerEarly 1<1 mi
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer PatientsPhase 1/2<1 mi
Converting HR+ Breast Cancer Into an Individualized VaccinePhase 2<1 mi
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During SurgeryPhase 1/2<1 mi
Study of AVZO-021 in Patients With Advanced Solid TumorsPhase 1/2<1 mi
Opioid Dispensing Device for Post-Operative Pain in Cancer PatientsN/A<1 mi
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)Phase 3<1 mi
A Study of LY4337713 in Participants With FAP-Positive Solid TumorsPhase 1<1 mi
Mammography and Breast Arterial Calcification: An Information-Sharing TrialN/A<1 mi
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)Phase 3<1 mi
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast CancerN/A<1 mi
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid TumorsPhase 1/2<1 mi
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida—<1 mi
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)Phase 2<1 mi
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursPhase 1<1 mi
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast CancerPhase 4<1 mi
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerPhase 3<1 mi
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad OncN/A<1 mi
An Ophthalmic Safety Study in Patients With Breast Cancer—<1 mi
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentPhase 2<1 mi
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCsPhase 1<1 mi
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast CancerPhase 1<1 mi
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsPhase 1<1 mi
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerPhase 1/2<1 mi
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid TumorsPhase 1/2<1 mi
Pancreatic Cancer Genetics—<1 mi
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer—<1 mi
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid TumorsPhase 1<1 mi
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsPhase 1/2<1 mi
Inpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Program in a Safety Net Hospital.N/A<1 mi
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLCPhase 1<1 mi
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid TumorsPhase 2<1 mi
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCPhase 3<1 mi
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung CancerPhase 1/2<1 mi
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers—<1 mi
Daratumumab in STK11 Mutated NSCLCPhase 2<1 mi
Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard TreatmentPhase 3<1 mi
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionPhase 1/2<1 mi
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesPhase 1<1 mi
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsPhase 1<1 mi
A Study of LY4170156 in Participants With Selected Advanced Solid TumorsPhase 1<1 mi
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid TumorsPhase 1/2<1 mi
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLCPhase 3<1 mi
A Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsPhase 1<1 mi
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung CancerPhase 1<1 mi
BBO-11818 in Adult Subjects With KRAS Mutant CancerPhase 1<1 mi
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLCPhase 1/2<1 mi
Safety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsPhase 1<1 mi
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsPhase 1/2<1 mi
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Phase 1<1 mi
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers—<1 mi
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerPhase 2<1 mi
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasPhase 1/2<1 mi
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung CancerPhase 1/2<1 mi
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesPhase 1/2<1 mi
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid MalignanciesPhase 1/2<1 mi
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLCPhase 2<1 mi
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)—<1 mi
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung CancerPhase 1/2<1 mi
Phase II Trial of Lung ChemoemobolizationPhase 2<1 mi
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsPhase 1<1 mi
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D MutationPhase 1<1 mi
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)Phase 1/2<1 mi
Safety and Efficacy of OBX-115 in Advanced Solid TumorsPhase 1/2<1 mi
Pembrolizumab for Advanced NSCLC and PS 2-3Phase 2<1 mi
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)Phase 2<1 mi
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic DisordersPhase 2<1 mi
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsPhase 1<1 mi
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy Following ChemoimmunotherapyPhase 2<1 mi
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With PembrolizumabPhase 1/2<1 mi
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia—<1 mi
AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).Phase 1<1 mi
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%Phase 3<1 mi
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsPhase 1/2<1 mi
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®Phase 2<1 mi
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer—<1 mi
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung CancerPhase 3<1 mi
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsPhase 1<1 mi
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsPhase 1<1 mi
DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung CancerPhase 2<1 mi
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionPhase 1/2<1 mi
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)Phase 2/3<1 mi
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)Phase 3<1 mi
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung CancerPhase 1<1 mi
A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung CancerPhase 1<1 mi
A Study of Mental Health Care in People With CancerN/A<1 mi
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionPhase 3<1 mi
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor TypesPhase 1/2<1 mi
Empathic Communication Skills (ECS) TrainingN/A<1 mi
Confocal Laser Endomicroscopy VERificationN/A<1 mi
Multilevel Intervention for Precision OncologyN/A<1 mi
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung CancerPhase 1<1 mi
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2Phase 1<1 mi
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationPhase 1/2<1 mi
Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer—<1 mi
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)Phase 3<1 mi
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsPhase 1/2<1 mi
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC PatientsPhase 1/2<1 mi
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsPhase 1<1 mi
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung CancerPhase 1<1 mi
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid TumorsPhase 1<1 mi
A Study of LY4175408 in Participants With Advanced CancerPhase 1<1 mi
U3-1402 in Metastatic or Unresectable Non-Small Cell Lung CancerPhase 1<1 mi
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing—<1 mi
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56Phase 1/2<1 mi
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerPhase 1/2<1 mi
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsPhase 1<1 mi
Study of RET Inhibitor TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene AbnormalitiesPhase 1/2<1 mi
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine CancersPhase 2<1 mi
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLCPhase 1/2<1 mi
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)Phase 3<1 mi
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C MutationPhase 1/2<1 mi
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid TumorsPhase 1/2<1 mi
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRASPhase 3<1 mi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC PatientsPhase 3<1 mi
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung CancerPhase 3<1 mi
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other CancersPhase 1/2<1 mi
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPhase 1<1 mi
Study of DF1001 in Patients with Advanced Solid TumorsPhase 1/2<1 mi
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)—<1 mi
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLCPhase 2<1 mi
A Long-term Extension Study of PCI-32765 (Ibrutinib)Phase 3<1 mi
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)Phase 1<1 mi
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic AlterationsPhase 1/2<1 mi
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsPhase 1<1 mi
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)Phase 1/2<1 mi
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2Phase 1<1 mi
National Cancer Institute "Cancer Moonshot Biobank"—<1 mi
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung CancerPhase 1/2<1 mi
A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study—<1 mi
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Phase 3<1 mi
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsPhase 1<1 mi
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking AbilityPhase 3<1 mi
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPhase 1/2<1 mi
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility StudyN/A<1 mi
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossPhase 1/2<1 mi
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLCPhase 1/2<1 mi
Phase I/IIa Study of H002 in NSCLC With Active EGFR MutationPhase 1/2<1 mi
Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer—<1 mi
GEMINI-NSCLC: NSCLC Biomarker Study—<1 mi
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsPhase 2<1 mi
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)Phase 3<1 mi
GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid TumorsPhase 1/2<1 mi
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsPhase 3<1 mi
Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based ChemotherapyPhase 1<1 mi
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsPhase 1<1 mi
A Phase I/II Study of VLS-1488 in Subjects With Advanced CancerPhase 1/2<1 mi
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASPhase 1/2<1 mi
Lung Cancer Biomarkers and Screening—<1 mi
Study of IDE397 in Participants With Solid Tumors Harboring MTAP DeletionPhase 1<1 mi
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsPhase 1<1 mi
Study of Oral MRT-2359 in Selected Cancer PatientsPhase 1/2<1 mi
WTC Chest CT Imaging Archive—<1 mi
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsPhase 1<1 mi
Ladarixin With Sotorasib in Advanced NSCLCPhase 1<1 mi
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid TumorsPhase 1<1 mi
A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C MutationPhase 2<1 mi
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)Phase 1/2<1 mi
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced MalignanciesPhase 1<1 mi
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)Phase 2<1 mi
First in Human Study of AZD9592 in Solid TumorsPhase 1<1 mi
Comprehensive Outcomes for After Cancer HealthN/A<1 mi
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsPhase 1<1 mi
Study of DF6215 in Patients with Advanced Solid TumorsPhase 1<1 mi
A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)Phase 1<1 mi
A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid TumorsPhase 1/2<1 mi
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung CancerPhase 1<1 mi
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerPhase 3<1 mi
A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)Phase 2<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 2<1 mi
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor MalignanciesPhase 1/2<1 mi
Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsPhase 1<1 mi
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid TumorPhase 1<1 mi
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)—<1 mi
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)Phase 1/2<1 mi
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular CarcinomaPhase 1<1 mi
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)N/A<1 mi
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation—<1 mi
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway AberrationsPhase 1<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)Phase 1<1 mi
Diversity and Inclusion in Research Underpinning Prevention and Therapy TrialsN/A<1 mi
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate RetreatmentPhase 2/3<1 mi
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaPhase 1/2<1 mi
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsPhase 2<1 mi
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver TransplantPhase 4<1 mi
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPhase 1/2<1 mi
The Dragon PLC Trial (DRAGON-PLC)N/A<1 mi
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer—<1 mi
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaPhase 1<1 mi
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsPhase 1/2<1 mi
Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resectable Liver Cancer Before SurgeryPhase 2<1 mi
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid MalignanciesPhase 1<1 mi
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver MetastasesPhase 2<1 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyPhase 3<1 mi
Brodalumab in the Treatment of Immune-Related Adverse EventsPhase 1<1 mi
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)Phase 2<1 mi
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsPhase 1<1 mi
HOPE Against Cancer Recurrence in HCCPhase 4<1 mi
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular CarcinomaPhase 2<1 mi
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary CancerPhase 2<1 mi
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsPhase 1/2<1 mi
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine RegimenPhase 3<1 mi
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsPhase 1/2<1 mi
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.Phase 24 mi
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesPhase 14 mi
First-in-human Study of 7MW4911 in GI CancerPhase 1/24 mi
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed GlioblastomaPhase 24 mi
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer—4 mi
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal CancerPhase 24 mi
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)Phase 24 mi
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 TargetedPhase 24 mi
ATATcH Alternating Treatment Plans for Advanced CancerPhase 24 mi
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-AdjustmentPhase 44 mi
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerPhase 24 mi
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Phase 35 mi
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])Phase 35 mi
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos StudyPhase 25 mi
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders—5 mi
Pilot Trial of Spiritual Care Interventions for Patients With CancerN/A5 mi
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)Phase 35 mi
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic CancerPhase 1/25 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 35 mi
Mobile Health for Adherence in Breast Cancer PatientsN/A5 mi
The PREDICT Registry:—5 mi
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisPhase 35 mi
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck CancerPhase 25 mi
Leveraging the Emergency Department (LEAD) StudyN/A6 mi
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone LymphomaPhase 36 mi
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.Phase 28 mi
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy DeliveryPhase 29 mi
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)Phase 29 mi
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)Phase 29 mi
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast CancerPhase 29 mi
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial CancerPhase 39 mi
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast CancerPhase 29 mi
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerPhase 19 mi
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial CancerPhase 39 mi
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast CancersN/A9 mi
Liver Transplantation in Intrahepatic Cholangiocarcinoma—9 mi
A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell CarcinomaN/A9 mi
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7Phase 2/39 mi
RADIANT: Pre-op Radiation With Abemaciclib and LetrozolePhase 19 mi
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology—9 mi
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer—10 mi
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics—11 mi
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)Phase 311 mi
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer PatientsPhase 311 mi
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health SystemN/A11 mi
Mosaic Trial for Stem Cell Transplant RecipientsN/A11 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung CancerPhase 311 mi
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung CancerPhase 312 mi
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic AlterationsPhase 312 mi
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors—12 mi
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialPhase 312 mi
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT—12 mi
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsPhase 112 mi
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Phase 212 mi
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by BayerPhase 312 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)Phase 212 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)Phase 2/312 mi
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)Phase 312 mi
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary BlastomaPhase 312 mi
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular CarcinomaPhase 212 mi
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving ImmunotherapyN/A12 mi
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder CancerPhase 212 mi
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerPhase 312 mi
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder CancerPhase 312 mi
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard TreatmentPhase 312 mi
A Study of DF6002 Alone and in Combination With NivolumabPhase 112 mi
Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer PatientsPhase 212 mi
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy—12 mi
DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or OsteosarcomaPhase 1/212 mi
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With SarcomaPhase 1/212 mi
First in Human, Dose Escalation Study of AN4005Phase 112 mi
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid TumorsPhase 112 mi
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.Phase 112 mi
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)Phase 112 mi
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid TumorsPhase 212 mi
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and ActivityN/A12 mi
Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AMLPhase 112 mi
Treatment of Radiation and Cisplatin Induced Toxicities with TempolPhase 212 mi
ZZ06 in Adult Patients With Advanced Solid Tumor MalignanciesPhase 112 mi
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesPhase 112 mi
PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCCEarly 112 mi
Phase I Study of Fractionated Stereotactic Radiation TherapyPhase 112 mi
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN LossPhase 212 mi
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).Phase 312 mi
A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2Phase 112 mi
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal CancerPhase 112 mi
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian CancerPhase 312 mi
Upfront Surgical Resection for Osteosarcoma—12 mi
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)N/A12 mi
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid TumorsPhase 112 mi
Molecular and Genomic Profiling of Head and Neck Tumors—12 mi
Reduced Intensity Haploidentical BMT for High Risk Solid TumorsPhase 212 mi
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Phase 312 mi
Digoxin Medulloblastoma StudyPhase 212 mi
Phase 1 Study of ACR-2316 in Specific Advanced Solid TumorsPhase 112 mi
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 112 mi
Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain AmyloidosisPhase 112 mi
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck CancerPhase 212 mi
Study of LYL314 in Aggressive Large B-Cell LymphomaPhase 1/212 mi
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Phase 312 mi
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponsePhase 312 mi
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AMLPhase 212 mi
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDSPhase 112 mi
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder CancerPhase 112 mi
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate CancerPhase 412 mi
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate CancerN/A12 mi
Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)Phase 1/212 mi
Cardiovascular Multimodality Imaging Study—12 mi
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN TrialsN/A12 mi
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesEarly 112 mi
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXdPhase 212 mi
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer—12 mi
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabPhase 312 mi
CDK and Body Composition Study—12 mi
Reiki Breast Surgery QOL Project for Women Undergoing Breast SurgeryN/A12 mi
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid LeukemiaPhase 112 mi
Intra-Operative Radiation Registry—12 mi
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast CancerN/A12 mi
Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung CancerPhase 112 mi
Cough Capture as a Portal Into the Lung—12 mi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialPhase 312 mi
EXoPERT EMERALD Clinical Study—12 mi
Centralized Screening Unit (CSU) at Montefiore-EinsteinN/A12 mi
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung CancerPhase 212 mi
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsPhase 212 mi
HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver CancerN/A12 mi
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIN/A12 mi
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT TrialPhase 312 mi
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCCPhase 212 mi
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme MalignanciesPhase 212 mi
Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With ImmunotherapyPhase 212 mi
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)Phase 212 mi
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerPhase 2/312 mi
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)Phase 312 mi
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)Phase 112 mi
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)—12 mi
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)Phase 312 mi
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Phase 312 mi
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerPhase 212 mi
Shield Post-Approval Study Protocol—12 mi
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—12 mi
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE TrialPhase 312 mi
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid TumorsPhase 1/212 mi
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)Phase 312 mi
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)Phase 212 mi
A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following RadiotherapyPhase 212 mi
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)Phase 212 mi
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid TumorsPhase 1/212 mi
A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)Phase 212 mi
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory NeuroblastomaPhase 212 mi
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple MyelomaPhase 112 mi
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)Phase 1/212 mi
NOURISH-T+: Promoting Healthy Eating and Exercise BehaviorsN/A12 mi
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALLPhase 212 mi
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)Phase 112 mi
Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid TumorsPhase 112 mi
AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord AllograftPhase 2/312 mi
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsPhase 1/212 mi
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromePhase 212 mi
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed MedulloblastomaPhase 212 mi
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome—12 mi
A Study of BG-C477 in Participants With Advanced Solid TumorsPhase 112 mi
XTX301 in Patients With Advanced Solid TumorsPhase 1/212 mi
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)Phase 312 mi
Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's LymphomaPhase 112 mi
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)Phase 212 mi
A Global Study of the PETAL Consortium—12 mi
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes—12 mi
DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine CancersPhase 112 mi
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple MyelomaPhase 1/212 mi
Study of Erdafitinib Intravesical Delivery System for Localized Bladder CancerPhase 1/212 mi
Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland TreatmentN/A12 mi
Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple MyelomaPhase 1/212 mi
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyPhase 312 mi
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple MyelomaPhase 112 mi
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical ProstatectomyPhase 212 mi
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic MalignanciesPhase 112 mi
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial TumorsPhase 212 mi
Pediatric Precision Laboratory Advanced Neuroblastoma TherapyPhase 212 mi
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young AdultsPhase 112 mi
Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain TumorsPhase 112 mi
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)Phase 312 mi
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian CancersPhase 112 mi
Pembrolizumab and Lenvatinib in Advanced Cervical CancerPhase 212 mi
Phase IB/II of CPX-351 for Relapse Prevention in AMLPhase 1/212 mi
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerPhase 312 mi
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast CancerPhase 1/212 mi
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaPhase 112 mi
Iscador® P (Mistletoe) Immunotherapy for Recurrent Osteogenic SarcomaPhase 212 mi
Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung CancerPhase 212 mi
A Study of ZL-1310 in Subjects With Small Cell Lung CancerPhase 112 mi
Support for Cancer Patients Awaiting NewsN/A12 mi
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsPhase 1/212 mi
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid TumorsPhase 1/212 mi
CT-95 in Advanced Cancers Associated With Mesothelin ExpressionPhase 112 mi
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.Phase 112 mi
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)Phase 1/212 mi
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)Phase 112 mi
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid TumorsPhase 1/212 mi
A Phase 1 Study of LNCB74 in Advanced Solid TumorsPhase 112 mi
A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsPhase 112 mi
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsPhase 1/212 mi
Post-operative Urinary Retention (POUR) Following Thoracic SurgeryPhase 1/212 mi
RAPA-201 Therapy of Solid TumorsPhase 1/212 mi
Evaluating Novel Therapies in ctDNA Positive GI CancersPhase 312 mi
A Study of ZW251 in Participants With Advanced Solid TumorsPhase 112 mi
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid TumoursPhase 1/212 mi
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform—12 mi
Testing RG1-VLP Vaccine to Prevent HPV-related CancersPhase 113 mi
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)Phase 313 mi
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer SurvivorsN/A13 mi
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)Phase 313 mi
Ultralow Dose PET Imaging of SSTR2 Radiotracer UptakePhase 213 mi
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-—13 mi
Ultralow Dose PET Imaging of 18F-FDG UptakePhase 213 mi
Ultralow Dose PET Imaging for PSMA ExpressionPhase 213 mi
Ultralow Dose PET Imaging for 18F-NaF UptakePhase 213 mi
Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study—13 mi
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial HepatectomyN/A13 mi
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha ExpressionPhase 213 mi
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) TrialN/A13 mi
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecPhase 214 mi
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesPhase 116 mi
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry—16 mi
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal CancerPhase 2/316 mi
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)Phase 316 mi
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver MetastasisEarly 116 mi
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)Phase 116 mi
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia GravisN/A16 mi
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of DiseasePhase 216 mi
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S TrialPhase 316 mi
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk CohortN/A16 mi
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell CarcinomaPhase 116 mi
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid TumorsPhase 116 mi
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)Phase 316 mi
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their BodyPhase 1/216 mi
A Study of GEN1106 in Participants With Solid TumorsPhase 116 mi
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsPhase 1/216 mi
A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This MedicinePhase 216 mi
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyPhase 216 mi
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid TumorsPhase 1/216 mi
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced CancersPhase 1/216 mi
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)Phase 216 mi
A Study of MGC026 in Participants With Advanced Solid TumorsPhase 116 mi
Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)—16 mi
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung CancerPhase 2/316 mi
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)Phase 316 mi
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyPhase 216 mi
Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic CancerPhase 116 mi
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on OsimertinibPhase 1/216 mi
A Study of V940/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)Phase 216 mi
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal MelanomaPhase 217 mi
Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)Phase 117 mi
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal SamplesN/A17 mi
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal AdenocarcinomaN/A17 mi
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)—17 mi
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic CancerPhase 1/217 mi
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase InhibitorsN/A17 mi
A Study to Learn More About How Well Sevabertinib (BAY 2927088) Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Phase 317 mi
Virtual Personalized Exercise Program for Lung Cancer PatientsN/A17 mi
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsPhase 1/217 mi
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management—17 mi
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs—17 mi
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal CancerPhase 217 mi
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular MelanomaPhase 217 mi
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)Phase 1/217 mi
National Liver Cancer Screening TrialPhase 417 mi
Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)Phase 317 mi
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone MetasPhase 217 mi
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)Phase 217 mi
Investigating Targetable Metabolic Pathways Sustaining Pancreatic CancerN/A17 mi
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic FistulaPhase 317 mi
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)N/A17 mi
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-TPhase 218 mi
An Internet-based Program to Help Cancer Survivors Manage PainN/A19 mi
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)Phase 219 mi
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE TrialPhase 319 mi
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast CancerPhase 319 mi
Collection of Sputum and Labeling for Lung Cancer—19 mi
Measuring Surgical Recovery After Radical Cystectomy—19 mi
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)Phase 319 mi
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)Phase 220 mi
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainPhase 220 mi
Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria—20 mi
Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic CancerPhase 221 mi
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCPhase 321 mi
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic LeukemiaPhase 221 mi
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast TumorsN/A21 mi
A Study of Enasidenib in People With T-Cell LymphomaPhase 222 mi
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With ChemotherapyPhase 222 mi
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerPhase 222 mi
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus LazertinibPhase 222 mi
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell MalignanciesPhase 122 mi
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin LymphomaPhase 122 mi
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone LymphomaPhase 322 mi
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsPhase 322 mi
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) InhibitorsPhase 322 mi
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung CancerPhase 222 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)Phase 322 mi
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung CancerPhase 322 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLCPhase 322 mi
The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey—25 mi
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid TumorsPhase 1/225 mi
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin LymphomaPhase 1/225 mi
Rutgers University Study of the Genetics of Breast Cancer.—25 mi
Endometrial Cell Collection With the PadKitN/A26 mi
realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL—26 mi
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)Phase 226 mi
A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)Phase 226 mi
Pancreatic Cancer Detection Consortium—26 mi
A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)Phase 126 mi
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell CarcinomaPhase 2/326 mi
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)Phase 2/326 mi
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid TumorsPhase 126 mi
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerPhase 126 mi
NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor MalignanciesPhase 1/226 mi
Study of NALIRIFOX in Advanced Unresectable Small Bowel TumorsPhase 226 mi
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)Phase 226 mi
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk WomenN/A26 mi
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid TumorsPhase 1/226 mi
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)Phase 326 mi
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)Phase 326 mi
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung CancerPhase 326 mi
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 ChangePhase 226 mi
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)Phase 226 mi
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)Phase 326 mi
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)Phase 326 mi
Observational Study Protocol: LIVER-R—26 mi
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal CancerPhase 327 mi
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.Phase 327 mi
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerPhase 327 mi
Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLCPhase 1/227 mi
The Leukemia and Lymphoma Society (LLS) National Research Registry—27 mi
Clinical Utility of WATS3D: A 5-Year Prospective Study—28 mi
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural MesotheliomaPhase 328 mi
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)Phase 1/228 mi
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)Phase 1/228 mi
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell LymphomaPhase 328 mi
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell DepletionPhase 228 mi
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid TumorsPhase 128 mi
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHLPhase 228 mi
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV InfectionPhase 228 mi
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive ChemotherapyPhase 228 mi
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/LymphomaEarly 128 mi
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)Phase 1/228 mi
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CarePhase 328 mi
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaPhase 328 mi
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)Phase 1/228 mi
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone LymphomaPhase 228 mi
A Youth-led Intervention to Reduce Healthcare Disparities in Cancer ScreeningN/A28 mi
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal CancerPhase 228 mi
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated CancersPhase 1/228 mi
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin LymphomaPhase 128 mi
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)Phase 228 mi
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin LymphomaPhase 1/228 mi
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)Phase 128 mi
Reducing Urban Cervical Cancer DisparitiesN/A28 mi
Spine Oncology Registry—28 mi
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)Phase 328 mi
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck CancerPhase 1/228 mi
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid TumorsPhase 128 mi
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular LymphomaPhase 228 mi
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate CancerPhase 1/228 mi
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLPhase 328 mi
MySmartSkin Online Skin Self-exam Intervention for Melanoma SurvivorsN/A28 mi
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial CancersPhase 128 mi
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.Phase 228 mi
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)Phase 328 mi
Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer SurvivorsN/A28 mi
SynKIR-310 for Relapsed/Refractory B-NHLPhase 128 mi
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid MalignanciesPhase 1/228 mi
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated CancersPhase 228 mi
A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)Phase 128 mi
Bright Ideas - CIN Feasibility StudyN/A28 mi
A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous CarcinomaPhase 228 mi
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell LymphomaPhase 328 mi
Naltrexone and Propranolol Combined With ImmunotherapyPhase 128 mi
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid TumorsPhase 128 mi
Addressing Genomic Disparities in Cancer SurvivorsN/A28 mi
A Mobile Health Intervention Among HispanicsN/A28 mi
Project CARE: CAncer Risk EvaluationN/A28 mi
A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal CancerPhase 328 mi
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)Phase 1/228 mi
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast CancerN/A28 mi
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerPhase 1/228 mi
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung CancerPhase 128 mi
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy—28 mi
KO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsPhase 128 mi
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cmPhase 228 mi
TELESCOPE- TELEhealth Shared Decision-making COachingN/A28 mi
Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung CancerN/A28 mi
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for HispanicsN/A28 mi
A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver FunctionPhase 128 mi
A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period.Phase 229 mi
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)Phase 229 mi
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination with XELOX or Irinotecan in Patients with Advanced Gastric CancerPhase 1/229 mi
A Dose Escalation Study of AV-380 in Cancer Patients With CachexiaPhase 129 mi
A First-in-Human Study of MEN2312 in Adults With Advanced Breast CancerPhase 129 mi
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast CancerPhase 229 mi
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsPhase 1/229 mi
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic AlterationsPhase 1/229 mi
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerPhase 2/329 mi
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)Phase 329 mi
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 InhibitorsPhase 329 mi
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage TumorsPhase 129 mi
The CDK4/6 Inhibitor Dosing Knowledge (CDK) StudyPhase 329 mi
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid CancerPhase 329 mi
Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial CancerPhase 329 mi
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel CancersPhase 229 mi
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene MutationPhase 229 mi
PRISM: Patient Experiences With PET Imaging in Prostate Cancer—29 mi
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Phase 329 mi
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung CancerPhase 1/229 mi
Rectal Spacers Use in Prostate Cancer Radiation TherapyN/A29 mi
A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP DeletionPhase 2/329 mi
Liquid Biopsy Based NGS in Newly Diagnosed NSCLCN/A30 mi
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerPhase 430 mi
PROton Therapy for Post Surgical Treatment of GYNecologic CancerPhase 230 mi
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder CancerPhase 330 mi
The Radiation Oncology Registry and Biosample Repository—30 mi
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During ChemotherapyN/A30 mi
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyN/A30 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)Phase 230 mi
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic AlterationsPhase 330 mi
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier—34 mi
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS MutationsPhase 334 mi
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBCPhase 234 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening—34 mi
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)Phase 334 mi
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast CancerPhase 1/234 mi
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerPhase 135 mi
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial CancerPhase 2/337 mi
Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced CancerN/A37 mi
Molecular Genetics Studies of Cancer Patients and Their Relatives—37 mi
Evaluation of an Online Prostate Cancer Screening Decision AidN/A37 mi
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2Phase 238 mi
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate CancerPhase 1/238 mi
Caris Biorepository Research Protocol—40 mi
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full FacePhase 442 mi
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer—42 mi
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C MutationPhase 342 mi
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals—42 mi
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus—42 mi
Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70)—43 mi
Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)Phase 143 mi
A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast CancerPhase 143 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Phase 243 mi
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)Phase 348 mi
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaPhase 2/348 mi
Decision Aid and Thyroid Nodules ManagementN/A48 mi
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCTPhase 348 mi
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple MyelomaPhase 248 mi
Raman Spectroscopy and Skin Cancer—48 mi
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid TumorsPhase 248 mi
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)Phase 348 mi
Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer SurvivorsN/A48 mi
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple MyelomaPhase 348 mi
Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and NeckPhase 348 mi
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)—48 mi
Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma MultiformeEarly 148 mi
CtDNA Based MRD Testing for NAC Monitoring in TNBC—48 mi
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast CancerPhase 148 mi
Definitive Radiation Therapy for Inoperable Breast CancerN/A48 mi
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast CancerEarly 148 mi
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain MetastasesPhase 248 mi
Definitive Radiation for High-Risk Spine MetastasesPhase 248 mi
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Phase 2/348 mi
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer SurvivorsN/A48 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.